This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Osteoarthritis (OA) is a common, debilitating condition for which there is no cure and no known cause. Prolotherapy (PrT) is an injection-based therapy for chronic musculoskeletal pain in which an irritant solution is injected at painful ligaments and tendons to produce stronger connective tissue and decrease pain. Although studies indicate the PrT is effective, its use has not been rigorously studied in human clinical trials.Participants in this study will be randomly assigned to receive one of three treatments: standard PrT, injections with a saline placebo, or a pamphlet with recommendations for home knee physical therapy. Injections will be given at Weeks 1, 5, and 9; participants will then be monitored for 1 year. A quality of life questionnaire and a pain survey will be used to assess participants. At study completion, participants who did not receive PrT will have the option to receive three sessions of PrT at no cost.
Showing the most recent 10 out of 459 publications